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Co-existence of genetically and antigenically diverse bovine
viral diarrhoea viruses in an endemic situation
Abstract
Bovine viral diarrhoea virus (BVDV) is an important cattle pathogen that causes acute or persistent
infections. These are associated with immunotolerance to the viral strain persisting in animals that
became infected early in their intrauterine development. To this date, the epidemiology of BVD in
Switzerland runs virtually undisturbed by control measures such as restrictions on animal traffic or
vaccination. Here, we analysed the viral genetics of 169 Swiss isolates and carried out crossed serum
neutralisation tests to assess the antigenic spectrum of BVDV strains present in the cattle population.
Besides confirming the presence of BVDV type 1 subgroups b, e, h and k, a single "orphan" BVDV-1
virus was detected that does not belong to any known BVDV-1 subgroup. No BVDV type 2 viruses
were detected, suggesting that they are rare or not present in the cattle population. Antigenic comparison
revealed significant differences between the different subgroups, with anti-1k immune serum having up
to tenfold lower neutralising activity against 1b, 1e and 1h subgroup viruses, which however may still
suffice to protect 1k-immune animals against superinfection by viruses of those other subgroups. Serum
from routinely vaccinated animals revealed generally low titres but good cross-neutralisation. A
geographic information system revealed that the viruses of the different subgroups are distributed in an
apparently randomised fashion in the cattle population. This geographic distribution pattern may reflect
peculiarities of the management practice in the Swiss cattle industry that, especially through annual
transhumance of up to 25% of the entire population in the alpine region, tend to optimise the spread of
BVDV.
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Abstract  1 
Bovine viral diarrhoea virus (BVDV) is an important cattle pathogen that causes 2 
acute or persistent infections. The latter are associated with immunotolerance to the 3 
viral strain persisting in animals that became infected early in their intrauterine 4 
development. To this date, the epidemiology of BVD in Switzerland runs virtually 5 
undisturbed by control measures such as restrictions on animal traffic or vaccination. 6 
Here, we analysed the viral genetics of 169 Swiss isolates and carried out crossed 7 
serum neutralisation tests to assess the antigenic spectrum of BVDV strains present 8 
in the cattle population.  Besides confirming the presence of BVDV type 1 subgroups 9 
b, e, h and k, a single “orphan” BVDV-1 virus was detected that does not belong to 10 
any known BVDV-1 subgroup. No BVDV type 2 viruses were detected, suggesting 11 
that they are rare or not present in the cattle population. Antigenic comparison 12 
revealed significant differences between the different subgroups, with anti-1k 13 
immune serum having up to tenfold lower neutralising activity against 1b, 1e and 1h 14 
subgroup viruses, which however may still suffice to protect 1k-immune animals 15 
against superinfection by viruses of those other subgroups. Serum from routinely 16 
vaccinated animals revealed generally low titres but good cross-neutralisation. A 17 
geographic information system revealed that the viruses of the different subgroups 18 
are distributed in an apparently randomised fashion in the cattle population. This 19 
geographic distribution pattern may reflect peculiarities of the management practice 20 
in the Swiss cattle industry that, especially through annual transhumance of up to 21 
25% of the entire population in the alpine region, tend to optimise the spread of 22 
BVDV. 23 
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1. Introduction 1 
Bovine viral diarrhoea virus (BVDV) is a widespread and economically important 2 
cattle pathogen. The virus belongs to the pestivirus genus of the flaviviridae family 3 
and is closely related to the classical swine fever virus and and border disease virus 4 
of sheep and more distantly to hepatitis C virus of humans. Its genome consists of 5 
single strand positive polarity RNA of a length of approximately 12.5kb. The single 6 
open reading frame is flanked by 5’- and 3’-untranslated regions (UTR) and encodes 7 
a single polyprotein of about 4000 kDa, which is co- and posttranslationally cleaved 8 
into the structural and nonstructural proteins. The region adjacent to the 5’UTR 9 
encodes a pestivirus-specific nonstructural autoprotease (Npro), followed by the 10 
coding regions for four structural proteins (the capsid (C) protein and the envelope 11 
glycoproteins Erns, E1 and E2) and six to seven nonstructural proteins (Meyers and 12 
Thiel, 1996).  13 
A hallmark of BVD viruses is their genetic diversity. In addition to two genotypes, 14 
referred to as 1 and 2, at least 13 subgroups can be differentiated in type 1 and two 15 
subgroups in type 2 viruses. Genetic typing of strains is most often done by 16 
sequence analysis in the 5’UTR or in the Npro coding region of the genome (Pellerin 17 
et al., 1994; Becher et al., 1997, 2003; Vilček et al., 2001, 2004; Falcone et al., 18 
2003;  Xu et al., 2006).  19 
The reason for the world-wide success of BVDV lies in its ability to cause two types 20 
of infection. The majority of transient (or “acute”) infections take a subclinical or mild 21 
course, with diarrhoea, coughing and low-grade fever. Acute infection of a 22 
seronegative, pregnant animal between the second and fourth month of gestation 23 
can lead to persistent infection of the foetus. Such foetuses may develop and be 24 
born normally but fail to mount an immune response to the infecting viral strain due 25 
to a highly specific immunotolerance (reviewed in Peterhans et al., 2006). 26 
Epidemiologically, these animals are crucial for the persistence of the virus in the 27 
 4
host population because they shed large quantities of virus throughout their lives. 1 
Persistent infections may be associated with poor performance and an increased 2 
frequency of other infections. Some PI animals may develop the invariably lethal 3 
mucosal disease, which is characterised by mucosal erosions and massive 4 
destruction of lymphoid tissue in the gastrointestinal tract (Liebler-Tenorio et al., 5 
2000).  6 
 7 
Due to the considerable economic losses caused by infection with BVD virus, 8 
national or regional eradication programmes have been initiated in several European 9 
countries, among them Sweden, Norway, Finland and Denmark where eradication is 10 
nearly completed. Countrywide BVD eradication is also underway in Austria, 11 
whereas in France, Italy and Germany regional programmes are run (Houe et al., 12 
2006). To date, BVD has remained essentially uncontrolled in Switzerland. Animal 13 
traffic, which involves transhumance for grazing in the Alps of about 25% of the 14 
cattle population in summer, has not been controlled for BVDV and vaccination has 15 
been used only sporadically, on just a few farms. With approximately 60% 16 
seropositive animals and 0.6% PI animals (Rüfenacht et al., 2000) and little change 17 
over the years, the current situation may well reflect the epidemiology of BVD in a 18 
large (1.6 million) cattle population undisturbed by control measures. This will 19 
change in 2008 when a country-wide compulsory eradication campaign will be 20 
launched. In this work, we have investigated the genetic and antigenic spectrum of 21 
BVDV and the geographic distribution of the different types and subgroups of BVD.  22 
 23 
2. Material and Methods 24 
2.1. RNA isolation and RT-PCR 25 
 Viral RNA was isolated from frozen organ samples of 145 PI animals autopsied 26 
between 1995 and 2006 at the Institute of Veterinary Pathology, Zürich. Small 27 
 5
pieces of skin, tongue, thyroid gland or abomasum had been stored at -20°C. 1 
Additionally, blood samples were collected from 39 animals diagnosed as PI animals 2 
during 2004 and 2005 at the Department of Farm Animals, Zürich. Prior to RNA 3 
isolation, approximately 30mg of frozen tissue was homogenised in RLT buffer 4 
(Qiagen AG, Hombrechtikon, Switzerland) using the Qiagen Tissue Lyser. The 5 
RNeasy mini and viral RNA mini kits from Qiagen were used following the 6 
manufacturer’s instructions for RNA isolations from tissues and sera, respectively. 7 
All RT-PCR reactions were done as one-step and single tube reactions using the 8 
OneStep RT-PCR kit from Qiagen.  9 
 10 
2.2. Oligonucleotides 11 
For amplification of the 5’UTR the pan-pesti primer pair 324/326 described 12 
previously (Vilček, 1994) was used, yielding a DNA fragment of 288 nucleotides 13 
based on the reference strain NADL (Collett et al., 1988). In selected cases, the 14 
whole Npro coding region was sequenced using the primer pair described by Becher 15 
et al. (1997). The primers for the E1-E2 region were designed using the Primer-16 
ExpressTM software from Applied Biosystems (Foster City, USA) and purchased 17 
from Microsynth GmbH, Balgach, Switzerland. Their positions in the BVDV strain 18 
NADL are as follows: 232, GYRTAAGRCCRRAYTGGTGGCC (2244-2265); 270h, 19 
GCCCATTCAGTAGTGTTGTGTTGA (2808-2832). 20 
 21 
2.3. Nucleotide sequencing 22 
PCR products to be sequenced were separated by 1% agarose gel electrophoresis 23 
and DNA fragments of the correct size were isolated using the QIAquick gel 24 
extraction kit (Qiagen). After spectrophotometrical measurement at 260nm, the 25 
required amount of DNA, primer and water (aqua ad iniectabilia, Dr. G.Bichsel AG, 26 
 6
Interlaken, Switzerland) was mixed and sent to Microsynth GmbH for sequencing. 1 
The economy run and premixed primer options were used. 2 
New accession numbers 5’UTR (Fig.1): CH-01-08 (EU180024), Pe515 (EU180025), 3 
C86_vaccine (EU180026), CH-04-05 (EU180027), CH-Maria (EU180028), CH-05-02 4 
(EU180029), CH-05-b1 (EU180030), CH-04-01b (EU180031), CH-04-B2 5 
(EU180031) 6 
New accession numbers Npro (Fig.2): CH-01-08 (EU180033), Pe515 (EU180034), 7 
CH04-05 (EU180035), CH-05-02 (EU180036), CH-05-b1 (EU180037), CH-04-01b 8 
(EU180038), CH-04-B2 (EU180039), CH-03-01 (EU180040), CH-03-02  9 
(EU180041), CH-95-11 (EU180042), CH-99-07 (EU180043), CS8644 (EU180044) 10 
New accession numbers E2: CH-01-08 (EU180045), Pe515 (EU180046), CH04-05 11 
(EU180047), CH-Maria (EU180048), CH-05-b1 (EU180049), CH-04-01b 12 
(EU180050), CH-04-B2 (EU180051), CH-03-01 (EU180052), CH-03-02 (EU180053), 13 
CH-95-11 (EU180054), CH-99-07 (EU180055) 14 
 15 
2.4. Analysis of data 16 
The sequencing data were assembled and aligned using the SeqMan (DNASTAR 17 
Inc., Madison, USA) and Clone Manager (Scientific & Educational software, Cary, 18 
USA) software, respectively. Phylogenetic analysis was performed using the 19 
programs included in the GCG software package as PILEUP for the multiple 20 
sequence alignment and PAUP for calculating the distances by the Kimura 2-21 
parameter method. Trees were constructed according to the neighbour-joining 22 
method with branch numbers indicating the percentage of 1000 bootstrap replicates. 23 
Branch lengths are proportional to genetic distances. The genetic classification was 24 
performed for BVDV genotype 1 as described by Vilček et al. (2001). 25 
To illustrate the origins of the BVDV isolates geographically, the ArcView GIS 26 
software from ESRI (Redlands, USA) was used. 27 
 7
 1 
2.5. Cells and Viruses 2 
Virus propagation, titration and serum neutralisation test (SNT) were performed on 3 
primary bovine turbinate cells as described by Schweizer et al. (2006). Cell culture 4 
medium (Earle’s minimal essential medium (MEM)) was purchased from Seromed 5 
(Biochrom, Munich, Germany), and foetal calf serum (FCS) was from Sigma or 6 
Oxoid GmbH (Wesel, Germany). FCS was free of BVDV and antibody to BVDV as 7 
tested by virus isolation and SNT, respectively. The BVDV-1a strains Pe515 and 8 
SD-1 were kindly provided by J. W. McCauley (Institute for Animal Health, Compton, 9 
UK) and by K. V. Brock (Auburn University College of Veterinary Medicine, Auburn, 10 
USA), respectively. The BVDV-2a strain CS8644 (Wolfmeyer et al., 1997) was kindly 11 
provided by G. Wolf (Institute of Medical Microbiology, Infectious and Epidemic 12 
Diseases, Munich, Germany). The BVDV-1 field strains CH-Maria, CH-04-05, CH-13 
05-b1 and CH-04-01b originate from sera of Swiss PI animals and were isolated, 14 
passaged and titrated on primary bovine turbinate cells as described above. Strain 15 
CH-01-08 was isolated from a frozen tissue sample (tongue) of a Swiss PI animal.  16 
 17 
2.6. Antisera 18 
Antisera against the strains CH-Maria, CH-04-05, CH-04-01b and CH-01-08 were 19 
obtained from the mothers of the respective PI animals. Blood samples were taken 20 
at four days, 16 months, three months and seven years, respectively, following the 21 
birth of the PI offspring. The mother of PI animal CH-05-b1 was no longer alive; 22 
therefore serum from a seropositive heifer of the same herd and the same age as 23 
the PI animal was used instead. The blood sample was taken approximately 11 24 
months after the acute infection. Antisera against SD-1 and CS8644 (kindly provided 25 
by G. Wolf) were obtained from experimentally infected animals as described by 26 
 8
Meier (P. Meier, doctoral thesis, University of Bern, 1998) and Wolfmeyer et al. 1 
(1997), respectively. 2 
 3 
2.7. Vaccination of animals 4 
After a preliminary quarantine of four weeks, a group of three antigen and antibody 5 
negative heifers was vaccinated with the commercially available Bovilis® BVD-MD 6 
vaccine (Intervet, Boxmeer, Netherlands) according to the manufacturer’s 7 
instructions. The animals were vaccinated twice at an interval of one month. A fourth 8 
animal was left untreated, in order to serve as a sentinel for unintentional BVDV field 9 
strain infections. The four animals were housed together in a separate stable for the 10 
entire duration of the experiment. Blood samples were taken at days 0, 14, 28, 42 11 
and 56 post-vaccination and antibody titres measured by SNT (see below) and 12 
ELISA as described previously (Rüfenacht et al., 2000). 13 
 14 
2.8. Serum neutralisation test (SNT) 15 
Complement inactivation (30 minutes at 56°C) of the antiserum was followed by 16 
dilution with MEM in 2-fold dilution steps. Virus stock was diluted in MEM to give a 17 
working suspension with a concentration of 2000 TCID50/ml. Of each antibody 18 
dilution 0.5ml was mixed with 0.5ml of the virus working suspension and incubated 19 
for one hour at 37°C and 5% CO2. Following incubation, each virus-antiserum 20 
mixture was allocated to eight wells (100µl each) of a 96 well microtitre plate seeded 21 
with bovine turbinate cells, yielding an approximate virus concentration of 100 22 
TCID50 per well. After five days of incubation at 37°C and 5% CO2, cells were fixed 23 
and stained for BVDV protein (Adler et al., 1994). The serum neutralisation titre is 24 
expressed as the reciprocal of the serum dilution capable to inhibit infection in 50% 25 
of the wells. Titres were calculated according to the method of Reed and Muench 26 
(Reed and Muench, 1938). In order for the SNT to be valid, the titration of the 27 
 9
working suspension had to yield a virus concentration of 600 to 6000 TCID50 /ml to 1 
result in 30 to 300 TCID50 per well. The neutralisation assay was done three times. 2 
The serological relatedness was expressed as coefficient of antigenic similarity (R) 3 
between each pair of strains (Archetti and Horsfall, 1950; Becher et al, 2003). 4 
 5 
3. Results 6 
Viral RNA was isolated from 145 tissue samples of PI animals, dating from 1995 to 7 
2006. Additionally, 39 blood samples of prospective clinical cases, diagnosed as 8 
persistently infected with BVDV, were included (from 2004 and 2005), yielding 184 9 
BVDV genomes. The viral genomic sequences from the 5’UTR were determined and 10 
identical sequences from the same herd excluded from further analysis. The 11 
remaining 169 viral sequences were compared to previously analysed isolates 12 
(Stalder et al., 2005) and BVDV sequences from GenBank. All isolates examined 13 
were of BVDV-1 type. Of the 169 sequences, 61 (36%) fit clearly into subgroup 1h, 14 
57 (34%) to 1e, 36 (21%) to 1k and 14 (8%) to 1b (Fig.1). Additional sequencing of 15 
the Npro coding region of representative isolates confirmed the assessment based on 16 
the 5’UTR (Fig. 2). One single isolate (CH-01-08) could not be classified in any 17 
known BVDV-1 subgroup (Figs. 1 and 2, preliminary labelled 1x). 18 
The phylogenetic tree generated from the 5’UTR of all Swiss isolates revealed 19 
remarkable differences in diversity within the subgroups. Isolates belonging to 20 
subgroup 1h showed particularly low diversity (Fig.1). Nucleotide identity within this 21 
subgroup ranged between 95% and 100%, with a median of 99%. Several closely 22 
related clusters containing up to 15 identical isolates were observed. Since the 23 
temporal and geographical origin of these viruses did not imply any epidemiological 24 
Titer strain A with antiserum B x titer strain B with antiserum A
Titer strain A with antiserum A x titer strain B with antiserum B
R = 100 x
 10
connection (Fig. 3), we additionally sequenced the whole Npro coding region and 1 
partial E1 and adjacent E2 coding regions of six of these isolates, two of which 2 
originated from animals of the same herd. The nucleotide sequence of the Npro 3 
region revealed small differences between all six isolates (Tab. 1). The majority were 4 
synonymous changes. The more variable E1 and E2 coding regions of the two 5 
isolates from animals living in the same herd were identical whereas the other four 6 
isolates showed differences (Tab. 1). However, the nucleotide substitutions resulted 7 
in changes of the amino acid sequence only in the E2 but not in the E1 coding 8 
regions of the genome (data not shown). 9 
In contrast to subgroup 1h, subgroup 1e was remarkably diverse (Fig.1). The 5’UTR 10 
nucleotide identity within the Swiss BVDV 1e sequences ranged between 87% and 11 
100%, with the median being 93%. Based on 5’UTR analysis, this subgroup seems 12 
to consist of several distinct clusters that are rather distant from each other (Fig. 1). 13 
Also in the Npro based phylogenetic tree subgroup 1e was the least clearly defined 14 
subgroup and yielded the lowest bootstrap value (Fig. 2).  In contrast to 1e and 1h, 15 
the subgroups 1b and 1k showed similar and more moderate within-subgroup 16 
diversities.  17 
In order to evaluate the possibility of geographical clustering of subgroups, we 18 
analysed the origin of the Swiss isolates by means of a geographic information 19 
system (Fig. 3). The viruses originated from PI animals from 23 of 26 Swiss cantons. 20 
Viruses of the four detected BVDV-1 subgroups appeared to be evenly distributed. 21 
We next analysed to what extent the genetic differences would be manifested at the 22 
antigenetic level. To this end, we performed cross-neutralisation tests using one 23 
virus strain of each of the four BVDV subgroups detected and the corresponding 24 
immune sera (henceforth referred to as “homologous”). Furthermore, serum of 25 
routinely vaccinated cattle was included to assess its neutralising capacity against 26 
the BVDV-1 subgroups of field strains. Since C86 the BVDV strain of the inactivated 27 
 11
Bovilis® vaccine that had been used to immunise the animals was not available for 1 
the neutralisation tests, we used strain Pe515 as a closely related representative of 2 
the BVDV-1a subgroup. As another member of subgroup 1a, we included the SD-1 3 
strain. In additional experiments, the unclassified Swiss strain CH-01-08 and a 4 
BVDV-2 field strain from Germany and their homologous antisera were included. 5 
The mean neutralising antibody titres are indicated in Table 2.   6 
As expected the homologous pairing yielded the highest antibody titres in all cases. 7 
Although all sera were able to neutralise every virus included in the comparison, we 8 
observed marked differences in the neutralisation titres of the various serum-virus 9 
pairs (Tab. 2). The neutralising activity of the serum raised with strain CH-05-b1 (1k) 10 
when tested against heterologous viruses was ten times lower than that observed in 11 
the homologous pairing.  Interestingly, and in contrast to the weak cross-12 
neutralisation by its serum, the isolate CH-05-b1 (1k) was generally very well 13 
neutralised by heterologous immune sera. Neutralisation activity against viral strains 14 
of the same subgroup (1a1 and 1a2) clearly exceeded that against viruses of different 15 
subgroups. Though showing generally low antibody titres, the serum from the 16 
vaccinated animal revealed a good cross-neutralisation of all BVDV-1 isolates 17 
tested. As expected, BVDV-2 was only weakly neutralised by the tested anti-BVDV-1 18 
sera (1 to 4% of the homologous titres). In contrast, the anti-BVDV-2 serum 19 
neutralised the tested BVDV-1 isolates better and showed a particularly strong 20 
neutralisation of strain CH-05-b1 (1k). The neutralisation results confirmed the field 21 
isolate CH-01-08 to be a member of the BVDV-1 species. However, the subgroup 22 
affiliation remains unclear.  23 
To assess the antigenic relatedness of the strains, the R-values were calculated. R-24 
values lower than, or equal to, 25 indicate a significant antigenic difference between 25 
two viruses (Archetti and Horsfall, 1950; Becher et al., 2003). Within the BVDV-1 26 
isolates, the strains CH-05-b1 (1k) and CH-Maria (1e) yielded R-values as low as 17 27 
 12
and 18, respectively (Table 3). As expected, the comparison of BVDV-1 and BVDV-2 1 
isolates revealed even lower R-values with a minimum value of two, demonstrating 2 
the weak antigenic relatedness between the two BVDV species. 3 
 4 
4. Discussion  5 
Previous epidemiological studies had indicated that infection with BVDV is 6 
widespread in Switzerland, with 60% of the cattle population being antibody-positive 7 
and the prevalence of PI animals at 0.6% (Rüfenacht et al., 2000). On average, PI 8 
animals were detected on one of eight farms, and no farm was found to be free of 9 
antibody-positive animals. Together with the fact that BVD was never controlled in 10 
animal trade and movement, and vaccination was used only sporadically, the 11 
genetic and antigenic pattern of BVD viral strains found in the cattle population may 12 
well reflect the epidemiology of this viral infection largely undisturbed by control 13 
measures.  14 
BVDV isolates can be classified in two genotypes. Though being present in USA 15 
(Pellerin et al., 1994; Ridpath et al., 1994; Tajima and Dubovi, 2005) and several 16 
European countries (Wolfmeyer et al., 1997; Pratelli et al., 2001; Couvreur et al., 17 
2002; Drew et al., 2002), BVDV-2 is less diverse and less widely distributed than 18 
BVDV-1. None of the 334 isolates characterised to date in Switzerland belongs to 19 
BVDV-2, indicating that type 2 viruses are absent or very rare in our cattle 20 
population.  21 
The Swiss viruses analysed to date originated from 244 farms located in 23 of 26 22 
Swiss cantons (Fig. 3) and their distribution reflects the higher density of cattle in the 23 
lowlands as compared to the alpine regions (F. Lüdi, doctoral thesis, University of 24 
Bern, 2004). The new sequencing results confirmed the presence of the BVDV-1 25 
subgroups b, e, h and k (Stalder et al. 2005). However, the degree of genetic 26 
diversity differed markedly between the subgroups (Figs. 1 and 2). In particular, 27 
 13
viruses of subgroup 1e were very diverse whereas those of subgroup 1h were 1 
genetically much more closely related. Interestingly, the narrow genetic spectrum of 2 
BVDV subgroup 1h holds true also when comparing the 5’UTR regions of viruses 3 
isolated from cattle in Austria, Italy, Slovakia, Spain and Moçambique (Figs. 1 and 2, 4 
strains G, IT99-4292-1, KM, Leon-6, M233IN/95 and M1096-5IN/95). The reasons 5 
for the narrow genetic spectrum of h subgroup viruses are unclear. Possible 6 
explanations include, among others, a relatively recent emergence of this subgroup, 7 
or emergence after a genetic bottleneck. 8 
 9 
A special case was the virus that, in contrast to the 333 other isolates, did not fit into 10 
any known subgroup of BVDV-1 (Figs. 1 and 2, labelled “1x”). This virus was 11 
isolated from an animal of a very rare ancient Swiss breed called “Rhätisches 12 
Grauvieh” and lived in a small herd in a remote valley of central Switzerland (1x, Fig. 13 
3). However, since another “Rhätisches Grauvieh” of different geographic origin, 14 
harboured a “normal” BVDV isolate (CH-03-02, Fig. 3), CH-01-08 might be a 15 
geographically restricted rather than breed-specific isolate. Confirmation of this 16 
theory would require systematic analysis of the local cattle population. As the 17 
infection occurred already in 2000, however, the origin of the virus is likely to remain 18 
unclear. 19 
 20 
In terms of evolution, the different viral strains compete for susceptible hosts. The 21 
results of the crossed neutralisation experiments may be relevant in this regard. We 22 
noted significant antigenic differences between viruses of some of the BVDV-1 23 
subgroups. In particular, serum directed against the representative of subgroup 1k 24 
only weakly neutralised viruses of other subgroups, whereas immune sera against 25 
viruses of the other subgroups were more cross-reactive with the 1k-virus. It must, 26 
however, be said, that from our results we cannot draw any conclusion as to the 27 
 14
extent of antigenic variation within the single BVD-1 subgroups – which would 1 
increase the significance of the differences between the subgroups. Nevertheless, 2 
crossed neutralisation between the different subgroups of BVDV-1 was markedly 3 
stronger than between BVDV-1 and BVDV-2. The very limited protection against 4 
infection with BVDV-2 in animals immune to BVDV-1 is believed to have contributed 5 
to the large outbreak of BVDV-2 in the USA and Canada in the late 80’s and early 6 
90’s (Pellerin et al., 1994). However, it seems that the relatively low extent of cross-7 
neutralisation observed between the 1k immune serum and the other subgroups of 8 
BVDV-1 is sufficient for cross-protection against superinfection in vivo.  9 
 10 
Why are the viruses of the different BVDV subgroups distributed in a seemingly 11 
randomised fashion in the cattle population of different regions (Fig. 3)? The most 12 
likely explanation may lie in the peculiarities of the management practices of the 13 
cattle industry. Somewhat ironically, these optimise the spread of different strains of 14 
BVD viruses quite efficiently. There are no restrictions on movement and trade of 15 
cattle with regard to BVDV. Vaccination against BVDV is used very infrequently and 16 
known to confer only very limited foetal protection, as also shown by the fact that 17 
one of the animals immunised with inactivated vaccine was infected with a field 18 
strain seven months after the last immunisation and gave birth to a PI calf (data not 19 
shown). Perhaps the single most important management aspect contributing to the 20 
lack of regional differences in the distribution of the different subgroups of BVDV is 21 
transhumance. Each year, over 350’000 of the 1.6 million Swiss cattle are sent to 22 
alpine regions for summer grazing. The majority of these animals are heifers in their 23 
first pregnancy. On the alpine meadows, animals of many farms of the lowlands, 24 
often of different regions, graze together. Some 70% of the animals of this age group 25 
are seronegative (Rüfenacht et al., 2000), i.e. not protected from infection. Together 26 
with the fact that one of eight farms has one or several, mostly young, PI animals, 27 
 15
the alpine grazing grounds represent a very efficient “mixing vessel” (Braun et al., 1 
1998) optimising the spread of viruses of the different subgroups to the different 2 
regions of the country. The mixing is also highly efficient because animals are often 3 
sent not to the nearest but rather to distant alpine regions.  4 
 5 
This situation will change dramatically with the launching of a country-wide 6 
eradication campaign in 2008. Within the first year of this campaign, all animals 7 
(except those from pure veal or beef fattening farms) will be tested for BVDV. Since 8 
every virus detected in all PI animals will be available for analysis, this will provide a 9 
snapshot view of the complete genetic pool of BVDV in a host population of some 10 
1.6 million host animals. This should also provide a unique opportunity to obtain 11 
insight into the epidemiological significance of rare variants such as isolate CH-01-12 
08 (1x, Figs. 1 and 2) and the extent of spillover of Border Disease viruses from 13 
sheep to cattle (Cranwell et al., 2007). Moreover, linking sequence information with 14 
the animal data bank and geographic information systems will provide an excellent 15 
opportunity to detect the routes in the cattle population taken by individual strains of 16 
BVDV.  17 
 18 
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Table 1 1 
 2 
Comparison of six closely related BVDV-1h isolates in different genome regions 3 
 4 
Genome region BVDV-1h isolates % nucleotide identity 
% amino acid 
 identity 
 CH-04-B2 -  
 CH-04-B3 100  
5’utr CH-95-11 100  
248nt a CH-99-07 100  
 CH-03-01 100  
 CH-03-02 100  
 CH-04-B2 - - 
 CH-04-B3 99 100 
Npro CH-95-11 99 100 
504nt a CH-99-07 98 98 
 CH-03-01 98 99 
 CH-03-02 99 100 
 CH-04-B2 - - 
 CH-04-B3 100 100 
E1/E2 CH-95-11 98 97 
510nt a CH-99-07 97 96 
 CH-03-01 96 94 
 CH-03-02 97 98 
 5 
 a length of sequences (nucleotides) 6 
Isolates originating from the same herd are highlighted (bold and italic). The 7 
sequences are compared to CH-04-B2. 8 
9 
 22
Table 2 1 
 2 
Antibody titre of different sera against homologous and heterologous BVDV strains 3 
 4 
Antisera BVD Virus isolates 
 1a ab 1 1a2 1h 1b 1k 1e 1x 2a 
α1a1 1155 808 559 489 600 556 392 43 
α1a2 10950 15350 4483 7153 5717 2743   
α1h 1420 1527 4250 1773 3747 874   
α1b 2110 2767 4083 7163 5227 1567   
α1k 380 308 362 506 3785 311 472 45 
α1e 15623 13833 11700 13600 22767 49950   
α1x 472    895  1670 14 
α2a 408    1110  215 4870 
 5 
a BVDV genotype, b BVDV subgroup 6 
Antibody titers are indicated as mean values from three repetitive neutralisation tests. The standard 7 
deviation was on average 19%. Homologous titres are highlighted in bold and italic.  8 
The following isolates were used: Pe515 (1a1), SD-1 (1a2), CH-04-01b (1h), CH-04-05 (1b), CH-05-b1 9 
(1k), CH-Maria (1e), CH-01-08 (1x) and CS8644 (2a). The serum from the vaccinated animal is 10 
identified as  α1a1.  11 
12 
 23
Table 3 1 
 2 
Coefficients of antigenic relatedness (R) between different BVDV isolates 3 
 4 
BVDV isolates 1a ab 1 1a2 1h 1b 1k 1e 1x 2a 
1a1 100 65 40 35 21 34 29 6 
1a2  100 33 42 17 20   
1h   100 50 29 21   
1b    100 31 23   
1k     100 18 27 5 
1e      100   
1x       100 2 
2a        100 
 5 
a BVDV genotype, b BVDV subgroup 6 
R-values are indicated as mean values from three neutralisation tests. The standard 7 
deviation was on average 16%. R-values <= 25, indicating significant antigenic 8 
differences between two isolates, are highlighted (bold and italic numbers). 9 
The following isolates were used: Pe515 (1a1), SD-1 (1a2), CH-04-01b (1h), CH-04-05 (1b), CH-05-b1 10 
(1k), CH-Maria (1e), CH-01-08 (1x) and CS8644 (2a). The serum from the vaccinated animal is 11 
identified as  α1a1. 12 
13 
 24
Fig.1: Phylogenetic analysis of new Swiss BVDV-1 isolates, based on the 5’UTR.  1 
Non-labelled branch ends represent new Swiss BVDV isolates. Swiss sequences labelled in bold 2 
were additionally analysed in the Npro coding region (Fig. 2). Sequences labelled in italics have 3 
newly been submitted to GenBank. Non-Swiss sequences included were obtained from GenBank. 4 
The nomenclature of subgroups is according to Vilček et al. (2001, 2004). Branch numbers (in italics) 5 
indicate the percentage of 1000 bootstrap replicates. Branch lengths are proportional to genetic 6 
distances.  7 
 8 
9 
 25
Fig. 2: Phylogenetic analysis of BVDV-1 and -2 isolates, based on the 504 nt Npro coding region. New 1 
Swiss sequences are labelled in bold. The nomenclature of subgroups a to k is according to Vilček et 2 
al. (2001, 2004). Subgroups l and m are labelled according to Xu et al. (2006). The sequence So 3 
CP/75 (subgroup 1l) is only 385 nt long. However, since constructing the tree with all sequences 4 
shortened to 385 nt did not change the basic structure of the tree, we included this strain to the 5 
analysis. Branch numbers (in italics) indicate the percentage of 1000 bootstrap replicates. Branch 6 
lengths are proportional to genetic distances. 7 
 8 
9 
 26
Fig. 3: Map of Switzerland showing cantonal borders and the geographical origin of the Swiss BVDV-1 
sequences analysed to date. The symbols depicted in the legend represent the different BVDV-1 2 
subgroups. Isolates identical in the 5’UTR that were further analysed in other genome regions (Tab. 3 
1) are highlighted by arrows. The dates in brackets represent the year of detection of the PI-animals. 4 
  5 
 6 
